<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(5)</volume><submitter>Russell JBW</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To investigate the prevalence of cardiometabolic risk factors (CMRFs), target organ damage (TOD) and its associated factors among adults in Freetown, Sierra Leone.&lt;h4>Design&lt;/h4>This community-based cross-sectional study used a stratified multistage random sampling method to recruit adult participants.&lt;h4>Setting&lt;/h4>The health screening study was conducted between October 2019 and October 2021 in Western Area Urban, Sierra Leone.&lt;h4>Participants&lt;/h4>A total of 2394 adult Sierra Leoneans aged 20 years or older were enrolled.&lt;h4>Outcome measure&lt;/h4>Anthropometric data, fasting lipid profiles, fasting plasma glucose, TOD, clinical profiles and demographic characteristics of participants were described. The cardiometabolic risks were further related to TOD.&lt;h4>Results&lt;/h4>The prevalence of known CMRFs was 35.3% for hypertension, 8.3% for diabetes mellitus, 21.1% for dyslipidaemia, 10.0% for obesity, 13.4% for smoking and 37.9% for alcohol. Additionally, 16.1% had left ventricular hypertrophy (LVH) by ECG, 14.2% had LVH by two-dimensional echo and 11.4% had chronic kidney disease (CKD). The odds of developing ECG-LVH were higher with diabetes (OR=1.255, 95% CI (0.822 to 1.916) and dyslipidaemia (OR=1.449, 95% CI (0.834 to 2.518). Associated factors for higher odds of Left Ventricular Mass Index by echo were dyslipidaemia (OR=1.844, 95% CI (1.006 to 3.380)) and diabetes mellitus (OR=1.176, 95% CI (0.759 to 1.823)). The odds of having CKD were associated with diabetes mellitus (OR=1.212, 95% CI (0.741 to 1.983)) and hypertension (OR=1.163, 95% CI (0.887 to 1.525)). A low optimal cut-off point for ECG-LVH (male 24.5 mm vs female 27.5 mm) was required to maximise sensitivity and specificity by a receiver operating characteristics curve since the odds for LVH by ECG were low.&lt;h4>Conclusions&lt;/h4>This study provides novel data-driven information on the burden of CMRF and its association with preclinical TOD in a resource-limited setting. It illustrates the need for interventions in improving cardiometabolic health screening and management in Sierra Leonean.</pubmed_abstract><journal>BMJ open</journal><pagination>e067643</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10193073</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Burden of cardiometabolic risk factors and preclinical target organ damage among adults in Freetown, Sierra Leone: a community-based health-screening survey.</pubmed_title><pmcid>PMC10193073</pmcid><pubmed_authors>Conteh S</pubmed_authors><pubmed_authors>Koroma TR</pubmed_authors><pubmed_authors>Conteh V</pubmed_authors><pubmed_authors>Coker J</pubmed_authors><pubmed_authors>Bockarie A</pubmed_authors><pubmed_authors>Sesay S</pubmed_authors><pubmed_authors>Samura SK</pubmed_authors><pubmed_authors>Abir OT</pubmed_authors><pubmed_authors>Kanu JS</pubmed_authors><pubmed_authors>Mahdi OZ</pubmed_authors><pubmed_authors>Smith M</pubmed_authors><pubmed_authors>Lakoh S</pubmed_authors><pubmed_authors>Jalloh A</pubmed_authors><pubmed_authors>Lisk DR</pubmed_authors><pubmed_authors>Russell JBW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Burden of cardiometabolic risk factors and preclinical target organ damage among adults in Freetown, Sierra Leone: a community-based health-screening survey.</name><description>&lt;h4>Objective&lt;/h4>To investigate the prevalence of cardiometabolic risk factors (CMRFs), target organ damage (TOD) and its associated factors among adults in Freetown, Sierra Leone.&lt;h4>Design&lt;/h4>This community-based cross-sectional study used a stratified multistage random sampling method to recruit adult participants.&lt;h4>Setting&lt;/h4>The health screening study was conducted between October 2019 and October 2021 in Western Area Urban, Sierra Leone.&lt;h4>Participants&lt;/h4>A total of 2394 adult Sierra Leoneans aged 20 years or older were enrolled.&lt;h4>Outcome measure&lt;/h4>Anthropometric data, fasting lipid profiles, fasting plasma glucose, TOD, clinical profiles and demographic characteristics of participants were described. The cardiometabolic risks were further related to TOD.&lt;h4>Results&lt;/h4>The prevalence of known CMRFs was 35.3% for hypertension, 8.3% for diabetes mellitus, 21.1% for dyslipidaemia, 10.0% for obesity, 13.4% for smoking and 37.9% for alcohol. Additionally, 16.1% had left ventricular hypertrophy (LVH) by ECG, 14.2% had LVH by two-dimensional echo and 11.4% had chronic kidney disease (CKD). The odds of developing ECG-LVH were higher with diabetes (OR=1.255, 95% CI (0.822 to 1.916) and dyslipidaemia (OR=1.449, 95% CI (0.834 to 2.518). Associated factors for higher odds of Left Ventricular Mass Index by echo were dyslipidaemia (OR=1.844, 95% CI (1.006 to 3.380)) and diabetes mellitus (OR=1.176, 95% CI (0.759 to 1.823)). The odds of having CKD were associated with diabetes mellitus (OR=1.212, 95% CI (0.741 to 1.983)) and hypertension (OR=1.163, 95% CI (0.887 to 1.525)). A low optimal cut-off point for ECG-LVH (male 24.5 mm vs female 27.5 mm) was required to maximise sensitivity and specificity by a receiver operating characteristics curve since the odds for LVH by ECG were low.&lt;h4>Conclusions&lt;/h4>This study provides novel data-driven information on the burden of CMRF and its association with preclinical TOD in a resource-limited setting. It illustrates the need for interventions in improving cardiometabolic health screening and management in Sierra Leonean.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2025-04-05T09:11:53.023Z</modification><creation>2025-04-05T09:11:53.023Z</creation></dates><accession>S-EPMC10193073</accession><cross_references><pubmed>37192807</pubmed><doi>10.1136/bmjopen-2022-067643</doi></cross_references></HashMap>